These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6127000)

  • 1. On metabolic effects of diuretics and beta-blockers. Results from a cross-sectional and longitudinal population study of women.
    Bengtsson C; Lennartsson J; Lindquist O; Lindstedt G; Lundberg PA; Noppa H; Sigurdsson JA; Tibblin E
    Acta Med Scand; 1982; 212(1-2):57-64. PubMed ID: 6127000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms and signs in relation to blood pressure and antihypertensive treatment. A cross-sectional and longitudinal population study of middle-aged Swedish women.
    Sigurdsson JA; Bengtsson C
    Acta Med Scand; 1983; 213(3):183-90. PubMed ID: 6133414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight in women--metabolic aspects. The population study of women in Göteborg 1968--1969.
    Noppa H; Bengtsson C; Björntorp P; Smith U; Tibblin E
    Acta Med Scand; 1978; 203(1-2):135-41. PubMed ID: 626110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High blood pressure in women. A cross-sectional and a longitudinal follow-up study.
    Sigurdsson JA
    Acta Med Scand Suppl; 1982; 669():1-39. PubMed ID: 6133416
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
    Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L
    Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
    Lungershausen YK; Abbey M; Nestel PJ; Howe PR
    J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and importance of metabolic side-effects during antihypertensive therapy.
    Elmfeldt D; Berglund G; Wedel H; Wilhelmsen L
    Acta Med Scand Suppl; 1983; 672():79-83. PubMed ID: 6138939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical cardiac risk factors during diuretic therapy.
    Hubbell FA; Weber MA; Winer RL; Rose DE
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):123-33. PubMed ID: 7092406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
    Kudoh T; Nagawaga T; Nakagawa I
    Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in blood pressure, lipids, lipoproteins and glucose metabolism in the Northern Sweden MONICA project 1986-99.
    Jansson JH; Boman K; Messner T
    Scand J Public Health Suppl; 2003; 61():43-50. PubMed ID: 14660247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Wada S; Nakayama M; Masaki K
    Clin Ther; 1982; 5(2):163-73. PubMed ID: 6130841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular diseases and clinical laboratory examination. (4). Metabolic abnormalities in hypertension and their modification by antihypertensive drugs].
    Ebihara A
    Rinsho Byori; 1983 Oct; 31(10):1073-7. PubMed ID: 6143841
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between changes in neck circumference and changes in blood pressure.
    Ben-Noun LL; Laor A
    Am J Hypertens; 2004 May; 17(5 Pt 1):409-14. PubMed ID: 15110899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mefruside treatment in hypertension.
    Henningsen NC; Bergengren B; Malmborg O; Pihl O; Renmarker K; Strand L
    Acta Med Scand; 1980; 208(4):272-8. PubMed ID: 7446207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.